- GlobeNewswire•7 days ago
PARSIPPANY, N. J. and LIVONIA, Mich., March 16, 2017-- Trinity Health, one of the largest hospital systems in the nation, and Pacira Pharmaceuticals, Inc., today announced they will collaborate to develop ...
- Motley Fool•8 days ago
Growing use of this company's opioid alternative is fueling investor optimism.
- MarketWatch•9 days ago
Pacira Pharmaceuticals stock rises 2% on positive late-stage trial for opioid-reducing pain medication
Pacira Pharmaceuticals Inc. shares rose 2% in premarket trade Tuesday after the company said its medication intended for postsurgical pain and opioid reduction met primary endpoints in a phase 4 clinical ...
PCRX : Summary for Pacira Pharmaceuticals, Inc. - Yahoo Finance
Pacira Pharmaceuticals, Inc. (PCRX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||44.25 x 100|
|Ask||73.00 x 100|
|Day's Range||46.40 - 48.25|
|52 Week Range||29.95 - 65.64|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-47.21|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|